Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
28372806 |
FEMALE | Adult |
Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS? | ||
Van Obberghen EK, Cohen M, Rocher F, Lebrun-Frenay C. Rev Neurol (Paris). 2017;173(4):222-224. |
||
Described here is the case of a 35-year-old woman, with a past history of beta thalassemia, bulimia and asthma, who was diagnosed with MS at age 26. | ||
8037190 |
MALE | Adult |
Fat embolism syndrome associated with asthma and sickle cell-beta(+)-thalassemia. | ||
Johnson K, Stastny JF, Rucknagel DL. Am J Hematol. 1994;46(4):354-7. |
||
Fat embolism syndrome associated with asthma and sickle cell-beta(+)-thalassemia. | ||
8037190 |
MALE | Adult |
Fat embolism syndrome associated with asthma and sickle cell-beta(+)-thalassemia. | ||
Johnson K, Stastny JF, Rucknagel DL. Am J Hematol. 1994;46(4):354-7. |
||
A 25-year-old African-American man with sickle cell-beta(+)-thalassemia presented with acute asthma of 2 days' duration. |